Skip to content
Screener

Omnicell OMCL Other Income (Expense)

Other Income (Expense) at other companies

Baxter International logo
Baxter InternationalBAX
-$6M-300%
ICU Medical logo
ICU MedicalICUI
-$236K-113%
Nutex Health Inc. logo
Nutex Health Inc.NUTX
$38K+101%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$82K+383%
Cencora logo
CencoraCOR
$16.88M-84.7%
Solventum logo
SolventumSOLV
-$9M-12.5%

Segments

By segment

See full
Reportable Segment$1.38M-40.7%

Other financials

Income statement

See full
Revenue$312.2M+7.4%
Gross profit$152.9M+19.8%
Operating income$32.4M+300%
Net income$24.3M+331%
EPS (diluted)$0.52+333%

Balance sheet

See full
Cash & equivalents$322.8M-25.2%
Total debt$31.8M-25.4%
Total equity$1.3B+2.2%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$68.3M+59.8%
CapEx$8.9M-24.1%
Free cash flow$59.4M+91.7%

Valuation

See full
Market cap$1.65B+13.3%
Enterprise value$1.36B+27.3%
P/E35.3×
P/S1.3×+0.1×

Profitability

See full
Gross margin44.8%+1.0pp
Operating margin4.6%+3.3pp
Net margin1.7%+1.1pp
FCF margin11.4%+2.1pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.6×+0.2×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: Omnicell’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000926326-26-000022
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Selling, general, and administrative100,18797,985202,177200,014
Total operating expenses120,486119,558243,995242,113
Income (loss) from operations32,4498,12049,303(3,499)
Interest and other income (expense), net1,3842,3331,4354,422
Income before income taxes33,83310,45350,738923
Provision for income taxes9,5444,81415,0912,307
Net income (loss)$24,289$5,639$35,647$(1,384)
Net income (loss) per share:

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Omnicell's other income (expense)?
Omnicell (OMCL) reported other income (expense) of $1.38M in Q2 2026.
How has Omnicell's other income (expense) changed year-over-year?
Omnicell's other income (expense) decreased by 40.7% year-over-year, from $2.33M to $1.38M.
What is the long-term trend for Omnicell's other income (expense)?
Over 3 years (2021 to 2025), Omnicell's other income (expense) has grown at a -36.0% compound annual growth rate (CAGR), from -$23.5M to $6.17M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Omnicell's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude